biotech
biotech Articles
Endocyte shares made a solid gain early on Monday after the company announced an update from the FDA.
Published:
Last Updated:
Clinical-stage biopharmaceutical company Kodiak Sciences has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Published:
Last Updated:
While they are more suited for aggressive accounts, these three biotech stocks trading under $10 that could provide investors with some solid upside potential.
Published:
Last Updated:
MannKind shares are continuing their rally from Tuesday when it was announced that United Therapeutics was licensing MannKind a dry powder formulation of treprostinil, the active ingredient in...
Published:
Last Updated:
ProQR Therapeutics shares made a massive gain early on Wednesday after the firm announced positive interim results from its Phase 1/2 clinical trial in patients with Leber's congenital amaurosis 10.
Published:
Last Updated:
Clinical-stage biopharmaceutical company Principia Biopharma has amended its filing with the SEC for its initial public offering.
Published:
Last Updated:
Clinical-stage drug maker Sutro Biopharma has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
InsysTherapeutics shares made a handy gain early on Thursday after the company announced an update from the FDA.
Published:
Last Updated:
The topic of acceptable costs versus acceptable results is one that may never have a final conclusion in which everyone agrees.
Published:
Last Updated:
Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from the FDA.
Published:
Last Updated:
Affimed shares more than doubled early on Tuesday after it was announced that the firm entered into a strategic collaboration agreement with Genentech.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.
Published:
Last Updated:
24/7 Wall St. has identified several biotech analyst calls from Wall Street wherein the analysts are projecting upside of 100% to about 400%.
Published:
Last Updated: